Iceland - Healthcare Expenditure on Pharmaceuticals and Medical Non-Durable Goods by All Financing Schemes
Since 2014, Iceland Healthcare Expenditure on Pharmaceuticals and Medical Non-Durable Goods by All Financing Schemes increased 5.7% year on year. In 2019, the country was number 6 among other countries in Healthcare Expenditure on Pharmaceuticals and Medical Non-Durable Goods by All Financing Schemes at €579.98 Per Capita. Iceland is overtaken by Luxembourg, which was ranked number 5 at €593.97 Per Capita and is followed by Ireland with €570.29 Per Capita. Switzerland ranked the highest with €1,048.7 Per Capita in 2019, a growth of 2.6% versus 2018. Liechtenstein, Germany and Belgium respectively ranked number 2, 3 and 4 in this ranking. Latvia recorded the best 5 years average growth at +7.4% per year, while Greece recorded the worst performance at -0.5% per year.
Loading...
| Date | Euros Per Capita |
|---|---|
| 2019 | 579.98 |
| 2018 | 568.33 |
| 2017 | 577.40 |
| 2016 | 525.97 |
| 2015 | 487.08 |
How does Iceland rank in Healthcare Expenditure on Pharmaceuticals and Medical Non-Durable Goods by All Financing Schemes?
| # | 33 Countries | Euros Per Capita | Last | YoY | 5‑years CAGR | ||
|---|---|---|---|---|---|---|---|
| 1 |
#1
Switzerland
|
1,048.70 | 2019 | +2.6 % | +4.7 % | View data | |
| 2 |
#2
Liechtenstein
|
860.32 | 2019 | +3.0 % | +2.4 % | View data | |
| 5 |
#5
Luxembourg
|
593.97 | 2019 | +0.9 % | +0.8 % | View data | |
| 6 |
#6
Iceland
|
579.98 | 2019 | +2.0 % | +5.7 % | View data | |
| 7 |
#7
Ireland
|
570.29 | 2019 | -0.4 % | +1.5 % | View data | |